Improvement in population‐based survival of stage IV NSCLC due to increased use of chemotherapy

Publisher： John Wiley & Sons Inc

E-ISSN： 1097-0215|136|5|E387-E395

ISSN： 0020-7136

Source： INTERNATIONAL JOURNAL OF CANCER, Vol.136, Iss.5, 2015-03, pp. : E387-E395

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Survival impact of surgical resection of primary tumor in patients with stage IV colorectal cancer: Results from a large population‐based cohort study

By  

CANCER, Vol. 120, Iss. 5, 2014-03 ,pp. : 683-691

John Wiley & Sons Inc

Access to resources Recommend Favorite

Administration of adjuvant chemotherapy for stage II‐III colon cancer patients: An European population‐based study

By  

INTERNATIONAL JOURNAL OF CANCER, Vol. 142, Iss. 7, 2018-04 ,pp. : 1480-1489

John Wiley & Sons Inc

Access to resources Recommend Favorite

Pathological factors associated with survival benefit from adjuvant chemotherapy (ACT): a population‐based study of bladder cancer

By  

BJU INTERNATIONAL, Vol. 116, Iss. 3, 2015-09 ,pp. : 373-381

John Wiley & Sons Inc

Access to resources Recommend Favorite

Stage IV breast cancer: a population‐based study about prognostic factors according to HER2 and HR status

By  

EUROPEAN JOURNAL OF CANCER CARE (ELECTRONIC), Vol. 24, Iss. 6, 2015-11 ,pp. : 920-928

John Wiley & Sons Inc

Access to resources Recommend Favorite

Oral Bisphosphonate Use and Total Knee/Hip Implant Survival: Validation of Results in an External Population‐Based Cohort

By  

ARTHRITIS & RHEUMATOLOGY, Vol. 66, Iss. 11, 2014-11 ,pp. : 3233-3240

John Wiley & Sons Inc

Access to resources Recommend Favorite